Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Progress and potential of non-inhibitory small molecule chaperones for the treatment of Gaucher disease and its implications for Parkinson disease
Authors
Keywords
-
Journal
Expert Review of Proteomics
Volume 13, Issue 5, Pages 471-479
Publisher
Informa UK Limited
Online
2016-04-21
DOI
10.1080/14789450.2016.1174583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibitor versus chaperone behaviour of d -fagomine, DAB and LAB sp 2 -iminosugar conjugates against glycosidases: A structure–activity relationship study in Gaucher fibroblasts
- (2016) Teresa Mena-Barragán et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A peptide-linked recombinant glucocerebrosidase for targeted neuronal delivery: Design, production, and assessment
- (2016) Paul A. Gramlich et al. JOURNAL OF BIOTECHNOLOGY
- Review of miglustat for clinical management in Gaucher disease type 1
- (2016) Can Ficicioglu Therapeutics and Clinical Risk Management
- Sustained Systemic Glucocerebrosidase Inhibition Induces Brain α-Synuclein Aggregation, Microglia and Complement C1q Activation in Mice
- (2015) Emily M. Rocha et al. ANTIOXIDANTS & REDOX SIGNALING
- GBA deficiency promotes SNCA/α-synuclein accumulation through autophagic inhibition by inactivated PPP2A
- (2015) Ting-Ting Du et al. Autophagy
- Eliglustat: A Review in Gaucher Disease Type 1
- (2015) Lesley J. Scott DRUGS
- Fluorescence-Quenched Substrates for Live Cell Imaging of Human Glucocerebrosidase Activity
- (2015) Anuj K. Yadav et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Selective loss of glucocerebrosidase activity in sporadic Parkinson’s disease and dementia with Lewy bodies
- (2015) Davide Chiasserini et al. Molecular Neurodegeneration
- Lentiviral Gene Therapy Using Cellular Promoters Cures Type 1 Gaucher Disease in Mice
- (2015) Maria Dahl et al. MOLECULAR THERAPY
- Mutant glucocerebrosidase in Gaucher disease recruits Hsp27 to the Hsp90 chaperone complex for proteasomal degradation
- (2015) Chunzhang Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Eliglustat tartrate for the treatment of adults with type 1 Gaucher disease
- (2015) Lunawati Bennett et al. Drug Design Development and Therapy
- Pharmacological Chaperones and Coenzyme Q10 Treatment Improves Mutant β-Glucocerebrosidase Activity and Mitochondrial Function in Neuronopathic Forms of Gaucher Disease
- (2015) Mario de la Mata et al. Scientific Reports
- Ratiometric Two-Photon Fluorescent Probe for Quantitative Detection of β-Galactosidase Activity in Senescent Cells
- (2014) Hyo Won Lee et al. ANALYTICAL CHEMISTRY
- Glucocerebrosidase deficits in sporadic Parkinson disease
- (2014) Karen E Murphy et al. Autophagy
- Glucocerebrosidase is shaking up the synucleinopathies
- (2014) Marina Siebert et al. BRAIN
- Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
- (2014) Alisdair McNeill et al. BRAIN
- The NCS-LSD cohort study: a description of the methods and analyses used to assess the long-term effectiveness of enzyme replacement therapy and substrate reduction therapy in patients with lysosomal storage disorders
- (2014) W. E. Henley et al. JOURNAL OF INHERITED METABOLIC DISEASE
- Cognitive impairment in carriers of glucocerebrosidase gene mutation in Parkinson disease patients
- (2014) Michalina Malec-Litwinowicz et al. Neurologia i Neurochirurgia Polska
- A GCase Chaperone Improves Motor Function in a Mouse Model of Synucleinopathy
- (2014) Franziska Richter et al. Neurotherapeutics
- Glucocerebrosidase mutations in Thai patients with Parkinson's disease
- (2014) Teeratorn Pulkes et al. PARKINSONISM & RELATED DISORDERS
- Macrophage Models of Gaucher Disease for Evaluating Disease Pathogenesis and Candidate Drugs
- (2014) E. Aflaki et al. Science Translational Medicine
- Lysosomal Adaptation: How the Lysosome Responds to External Cues
- (2014) C. Settembre et al. Cold Spring Harbor Perspectives in Biology
- Mitochondria and Quality Control Defects in a Mouse Model of Gaucher Disease—Links to Parkinson’s Disease
- (2013) Laura D. Osellame et al. Cell Metabolism
- Atp13a2-deficient mice exhibit neuronal ceroid lipofuscinosis, limited α-synuclein accumulation and age-dependent sensorimotor deficits
- (2013) Patrick J. Schultheis et al. HUMAN MOLECULAR GENETICS
- TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
- (2013) Carmine Settembre et al. NATURE CELL BIOLOGY
- Effects of imiglucerase on the growth and metabolism of Gaucher disease type I patients: a systematic review
- (2013) Divair Doneda et al. Nutrition & Metabolism
- Histone deacetylase inhibitors increase glucocerebrosidase activity in Gaucher disease by modulation of molecular chaperones
- (2013) C. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Augmenting CNS glucocerebrosidase activity as a therapeutic strategy for parkinsonism and other Gaucher-related synucleinopathies
- (2013) S. Pablo Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Disruption of Protein Quality Control in Parkinson's Disease
- (2013) C. Cook et al. Cold Spring Harbor Perspectives in Medicine
- A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
- (2013) Michael A. Nalls et al. JAMA Neurology
- Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains
- (2012) Matthew E. Gegg et al. ANNALS OF NEUROLOGY
- MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB
- (2012) Jose A. Martina et al. Autophagy
- Pilot study using ambroxol as a pharmacological chaperone in type 1 Gaucher disease
- (2012) Ari Zimran et al. BLOOD CELLS MOLECULES AND DISEASES
- Ambroxol as a pharmacological chaperone for mutant glucocerebrosidase
- (2012) Inna Bendikov-Bar et al. BLOOD CELLS MOLECULES AND DISEASES
- The chaperone activity and toxicity of ambroxol on Gaucher cells and normal mice
- (2012) Zhuo Luan et al. BRAIN & DEVELOPMENT
- Velaglucerase Alfa for the Management of Type 1 Gaucher Disease
- (2012) Jennifer L. Morris CLINICAL THERAPEUTICS
- A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
- (2012) Carmine Settembre et al. EMBO JOURNAL
- Discovery, Structure–Activity Relationship, and Biological Evaluation of Noninhibitory Small Molecule Chaperones of Glucocerebrosidase
- (2012) Samarjit Patnaik et al. JOURNAL OF MEDICINAL CHEMISTRY
- The link between the GBA gene and parkinsonism
- (2012) Ellen Sidransky et al. LANCET NEUROLOGY
- Pharmacological chaperones facilitate the post-ER transport of recombinant N370S mutant β-glucocerebrosidase in plant cells: Evidence that N370S is a folding mutant
- (2012) Gholamreza Babajani et al. MOLECULAR GENETICS AND METABOLISM
- Lysosome-dependent pathways as a unifying theme in Parkinson's disease
- (2012) George K. Tofaris MOVEMENT DISORDERS
- Glucocerebrosidase inhibition causes mitochondrial dysfunction and free radical damage
- (2012) Michael W.J. Cleeter et al. NEUROCHEMISTRY INTERNATIONAL
- High Throughput Screening for Small Molecule Therapy for Gaucher Disease Using Patient Tissue as the Source of Mutant Glucocerebrosidase
- (2012) Ehud Goldin et al. PLoS One
- Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease
- (2012) L. M. Panicker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Transcription Factor TFEB Links mTORC1 Signaling to Transcriptional Control of Lysosome Homeostasis
- (2012) A. Roczniak-Ferguson et al. Science Signaling
- Chaperone-mediated autophagy: a unique way to enter the lysosome world
- (2012) Susmita Kaushik et al. TRENDS IN CELL BIOLOGY
- Acid β-glucosidase mutants linked to gaucher disease, parkinson disease, and lewy body dementia alter α-synuclein processing
- (2011) Valerie Cullen et al. ANNALS OF NEUROLOGY
- Microautophagy in mammalian cells: Revisiting a 40-year-old conundrum
- (2011) Dalibor Mijaljica et al. Autophagy
- How I treat Gaucher disease
- (2011) A. Zimran BLOOD
- Gaucher Disease Glucocerebrosidase and α-Synuclein Form a Bidirectional Pathogenic Loop in Synucleinopathies
- (2011) Joseph R. Mazzulli et al. CELL
- Ex Vivoandin VivoEffects of Isofagomine on Acid β-Glucosidase Variants and Substrate Levels in Gaucher Disease
- (2011) Ying Sun et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Evaluation of Quinazoline Analogues as Glucocerebrosidase Inhibitors with Chaperone Activity
- (2011) Juan J. Marugan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Lysosomal accumulation of Trk protein in brain of GM1-gangliosidosis mouse and its restoration by chemical chaperone
- (2011) Ayumi Takamura et al. JOURNAL OF NEUROCHEMISTRY
- Isofagomine In Vivo Effects in a Neuronopathic Gaucher Disease Mouse
- (2011) Ying Sun et al. PLoS One
- CNS expression of glucocerebrosidase corrects -synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy
- (2011) S. P. Sardi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TFEB Links Autophagy to Lysosomal Biogenesis
- (2011) C. Settembre et al. SCIENCE
- Type 2 Gaucher disease: Phenotypic variation and genotypic heterogeneity
- (2010) N. Gupta et al. BLOOD CELLS MOLECULES AND DISEASES
- A monozygotic twin pair with highly discordant Gaucher phenotypes
- (2010) M. Biegstraaten et al. BLOOD CELLS MOLECULES AND DISEASES
- A Fluorescent sp2-Iminosugar With Pharmacological Chaperone Activity for Gaucher Disease: Synthesis and Intracellular Distribution Studies
- (2010) Zhuo Luan et al. CHEMBIOCHEM
- Chaperone-mediated autophagy in protein quality control
- (2010) Esperanza Arias et al. CURRENT OPINION IN CELL BIOLOGY
- The pharmacological chaperone isofagomine increases the activity of the Gaucher disease L444P mutant form of β-glucosidase
- (2010) Richie Khanna et al. FEBS Journal
- Eaten alive: a history of macroautophagy
- (2010) Zhifen Yang et al. NATURE CELL BIOLOGY
- Ultrasensitive in situ visualization of active glucocerebrosidase molecules
- (2010) Martin D Witte et al. Nature Chemical Biology
- The delivery of endocytosed cargo to lysosomes: Figure 1
- (2009) J. Paul Luzio et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Promising results of the chaperone effect caused by iminosugars and aminocyclitol derivatives on mutant glucocerebrosidases causing Gaucher disease
- (2009) Gessamí Sánchez-Ollé et al. BLOOD CELLS MOLECULES AND DISEASES
- Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
- (2009) Gustavo H. B. Maegawa et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Alpha-synuclein-glucocerebrosidase interactions in pharmacological Gaucher models: A biological link between Gaucher disease and parkinsonism
- (2009) Amy B. Manning-Boğ et al. NEUROTOXICOLOGY
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's Disease
- (2009) E. Sidransky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Glycosidase inhibition: assessing mimicry of the transition state
- (2009) Tracey M. Gloster et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Randomized, controlled trial of miglustat in Gaucher's disease type 3
- (2008) Raphael Schiffmann et al. ANNALS OF NEUROLOGY
- Enhanced autophagy and mitochondrial aberrations in murine GM1-gangliosidosis
- (2008) Ayumi Takamura et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Principles of lysosomal membrane degradation
- (2008) Heike Schulze et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
- (2008) Kathleen S. Hruska et al. HUMAN MUTATION
- Autophagy fights disease through cellular self-digestion
- (2008) Noboru Mizushima et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started